02/14/2025
7:48 AM | Deep Track Capital, LP (Filed by)
OnKure Therapeutics, Inc. (Subject)
OnKure Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
02/06/2025
8:09 PM | Lundbeckfond Invest A/S (Filed by)
OnKure Therapeutics, Inc. (Subject)
OnKure Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/31/2025
8:56 AM | OnKure Therapeutics, Inc. (Subject)
OnKure Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SCHEDULE 13G | |
01/29/2025
7:33 PM | Agresta Samuel (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
7:33 PM | Hartley Dylan (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
7:35 PM | Leverone Jason A. (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2025
7:36 PM | OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
Saccomano Nicholas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
5:38 PM | OnKure Therapeutics, Inc. (Subject)
OnKure Therapeutics (Subject)
RiverVest Venture Fund III, L.P. (Filed by)
| Form SCHEDULE 13D/A | |
12/10/2024
6:05 AM | OnKure Therapeutics, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2024
6:07 AM | OnKure Therapeutics, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form 424B3 | |
12/09/2024
3:30 PM | OnKure Therapeutics, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
Get the Latest News and Ratings for OKUR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for OnKure Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
11/14/2024
9:11 AM | HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
OnKure Therapeutics, Inc. (Subject)
OnKure Therapeutics (Subject)
| Form SC 13G | |
10/31/2024
3:07 PM | OnKure Therapeutics, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form 424B3 | |
10/30/2024
11:15 PM | OnKure Therapeutics, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form EFFECT | |
10/28/2024
3:03 PM | Octagon Capital Advisors LP (Filed by)
OnKure Therapeutics, Inc. (Subject)
OnKure Therapeutics (Subject)
| Form SC 13G/A | |
10/23/2024
3:15 PM | Deep Track Capital, LP (Filed by)
OnKure Therapeutics, Inc. (Subject)
OnKure Therapeutics (Subject)
| Form SC 13G/A | |
10/21/2024
1:24 PM | OnKure Therapeutics, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
10/16/2024
3:30 PM | Cormorant Asset Management, LP (Filed by)
OnKure Therapeutics, Inc. (Subject)
OnKure Therapeutics (Subject)
| Form SC 13G/A | |
10/15/2024
3:08 PM | Chen Bihua (Reporting)
Cormorant Asset Management, LP (Reporting)
Cormorant Global Healthcare Master Fund, LP (Reporting)
Cormorant Private Healthcare Fund III LP (Reporting)
Cormorant Private Healthcare Fund IV LP (Reporting)
Cormorant Private Healthcare Fund V LP (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/11/2024
4:24 PM | CITADEL ADVISORS LLC (Filed by)
OnKure Therapeutics, Inc. (Subject)
OnKure Therapeutics (Subject)
| Form SC 13G | |
10/11/2024
3:15 PM | OnKure Therapeutics, Inc. (Subject)
OnKure Therapeutics (Subject)
Samsara BioCapital, L.P. (Filed by)
| Form SC 13G | |
10/10/2024
5:57 PM | OnKure Therapeutics, Inc. (Subject)
OnKure Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G | |
10/10/2024
3:30 PM | Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
OnKure Therapeutics, Inc. (Subject)
OnKure Therapeutics (Subject)
| Form SC 13D/A | |
10/09/2024
3:15 PM | ACORN BIOVENTURES, L.P. (Reporting)
ACORN CAPITAL ADVISORS GP, LLC (Reporting)
Hove Anders D (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/09/2024
10:40 AM | BML Investment Partners, L.P. (Filed by)
OnKure Therapeutics, Inc. (Subject)
OnKure Therapeutics (Subject)
| Form SC 13G/A | |
10/09/2024
10:25 AM | Leonard Braden Michael (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
6:34 PM | New Enterprise Associates 15, L.P. (Filed by)
OnKure Therapeutics, Inc. (Subject)
OnKure Therapeutics (Subject)
| Form SC 13D/A | |
10/08/2024
6:06 PM | Agresta Samuel (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/08/2024
6:07 PM | Carruthers R Michael (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/08/2024
6:09 PM | Hartley Dylan (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/08/2024
6:09 PM | Jansen Valerie Malyvanh (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/08/2024
6:10 PM | Leverone Jason A. (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/08/2024
6:11 PM | Manke Isaac (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/08/2024
6:12 PM | OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
Phillips Andrew John (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/08/2024
6:14 PM | OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
Saccomano Nicholas A (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/08/2024
6:20 PM | Agresta Samuel (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
6:21 PM | Carruthers R Michael (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
6:23 PM | GREY MICHAEL G (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
6:24 PM | Hartley Dylan (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
6:25 PM | Jansen Valerie Malyvanh (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
6:26 PM | Leverone Jason A. (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Collect $7k per month from Tesla’s SECRET dividend (Ad) There's a little-known secret about Tesla that even seasoned investors don't know.
Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month.
This backdoor strategy is changing the game for smart investors.
Want to see how it works? Click here to uncover Tesla's hidden income secret. |
10/08/2024
6:27 PM | Manke Isaac (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
6:27 PM | Mathers Edward T (Reporting)
OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
6:28 PM | OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
Phillips Andrew John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
6:29 PM | OnKure Therapeutics, Inc. (Issuer)
OnKure Therapeutics (Issuer)
Saccomano Nicholas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
4:26 PM | OnKure Therapeutics, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
4:20 PM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
4:23 PM | Reneo Pharmaceuticals, Inc. (Subject)
OnKure Therapeutics (Subject)
| Form 425 | |
09/26/2024
8:33 AM | Leonard Braden Michael (Reporting)
Reneo Pharmaceuticals, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
6:04 AM | Reneo Pharmaceuticals, Inc. (Subject)
OnKure Therapeutics (Subject)
| Form 425 | |
09/20/2024
6:00 AM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
10:02 AM | Leonard Braden Michael (Reporting)
Reneo Pharmaceuticals, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
3:21 PM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/26/2024
11:15 PM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form EFFECT | |
08/26/2024
4:06 PM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form 424B3 | |
08/26/2024
4:06 PM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form 424B3 | |
08/26/2024
5:10 AM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form S-4/A | |
08/19/2024
5:06 AM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form S-4/A | |
08/14/2024
7:48 PM | Leonard Braden Michael (Reporting)
Reneo Pharmaceuticals, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/26/2024
8:59 PM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form S-4/A | |
05/21/2024
9:12 AM | BML Investment Partners, L.P. (Filed by)
Reneo Pharmaceuticals, Inc. (Subject)
OnKure Therapeutics (Subject)
| Form SC 13G/A | |
05/16/2024
7:56 AM | Leonard Braden Michael (Reporting)
Reneo Pharmaceuticals, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/16/2024
7:58 AM | Leonard Braden Michael (Reporting)
Reneo Pharmaceuticals, Inc. (Issuer)
OnKure Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
8:14 AM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
8:38 AM | Reneo Pharmaceuticals, Inc. (Subject)
OnKure Therapeutics (Subject)
| Form 425 | |
04/26/2024
5:16 AM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form 10-K/A | |
03/28/2024
3:05 PM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/28/2024
3:00 PM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
3:01 PM | Reneo Pharmaceuticals, Inc. (Filer)
OnKure Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
